These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18382005)

  • 1. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C.
    Latka MH; Hagan H; Kapadia F; Golub ET; Bonner S; Campbell JV; Coady MH; Garfein RS; Pu M; Thomas DL; Thiel TK; Strathdee SA
    Am J Public Health; 2008 May; 98(5):853-61. PubMed ID: 18382005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).
    Kapadia F; Latka MH; Hagan H; Golub ET; Campbell JV; Coady MH; Garfein RS; Thomas DL; Bonner S; Thiel T; Strathdee SA
    J Urban Health; 2007 Jan; 84(1):99-115. PubMed ID: 17200799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness.
    Korthuis PT; Feaster DJ; Gomez ZL; Das M; Tross S; Wiest K; Douaihy A; Mandler RN; Sorensen JL; Colfax G; McCarty D; Cohen SE; Penn PE; Lape D; Metsch LR
    Addict Behav; 2012 Apr; 37(4):552-5. PubMed ID: 22209655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
    AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
    Burt RD; Thiede H; Hagan H
    Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users.
    Cox J; De P; Morissette C; Tremblay C; Stephenson R; Allard R; Graves L; Roy E
    Soc Sci Med; 2008 Jan; 66(2):211-20. PubMed ID: 17920741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distributive syringe sharing among young adult injection drug users in five U.S. cities.
    Golub ET; Strathdee SA; Bailey SL; Hagan H; Latka MH; Hudson SM; Garfein RS;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S30-8. PubMed ID: 17398039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician.
    Jauffret-Roustide M; Cohen J; Poisot-Martin I; Spire B; Gossop M; Carrieri MP;
    AIDS Care; 2012; 24(2):232-8. PubMed ID: 21777078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
    Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
    Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.
    Roux P; Le Gall JM; Debrus M; Protopopescu C; Ndiaye K; Demoulin B; Lions C; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri MP
    Addiction; 2016 Jan; 111(1):94-106. PubMed ID: 26234629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users.
    Vidal-Trecan GM; Varescon-Pousson I; Gagnière B; Tcherny- Lessenot S; Madariaga E; Boissonnas A
    Ann Med Interne (Paris); 2002 Jun; 153(4):219-25. PubMed ID: 12218887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial.
    Hochstatter KR; Hull SJ; Sethi AK; Burns ME; Mundt MP; Westergaard RP
    J Med Internet Res; 2020 Sep; 22(9):e19703. PubMed ID: 32990630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.
    Villano SA; Vlahov D; Nelson KE; Lyles CM; Cohn S; Thomas DL
    J Clin Microbiol; 1997 Dec; 35(12):3274-7. PubMed ID: 9399533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.
    Thorpe LE; Ouellet LJ; Hershow R; Bailey SL; Williams IT; Williamson J; Monterroso ER; Garfein RS
    Am J Epidemiol; 2002 Apr; 155(7):645-53. PubMed ID: 11914192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.
    Pouget ER; Hagan H; Des Jarlais DC
    Addiction; 2012 Jun; 107(6):1057-65. PubMed ID: 22168373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.
    Novelli LA; Sherman SG; Havens JR; Strathdee SA; Sapun M
    Drug Alcohol Depend; 2005 Mar; 77(3):303-9. PubMed ID: 15734230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.